Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

Hiroshi Moritake; Shiro Tanaka; Hideki Nakayama; Takako Miyamura; Shotaro Iwamoto; Akira Shimada; Kiminori Terui; Akiko Saito; Norio Shiba; Yasuhide Hayashi; Daisuke Tomizawa; Takashi Taga; Hiroaki Goto; Daisuke Hasegawa; Keizo Horibe; Shuki Mizutani; Souichi Adachi

doi:10.1002/pbc.26491

Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

Hiroshi Moritake, Shiro Tanaka, Hideki Nakayama, Takako Miyamura, Shotaro Iwamoto, Akira Shimada, Kiminori Terui, Akiko Saito, Norio Shiba, Yasuhide Hayashi, Daisuke Tomizawa, Takashi Taga, Hiroaki Goto, Daisuke Hasegawa, Keizo Horibe, Shuki Mizutani, Souichi Adachi

University Hospital

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Article number	e26491
Journal	Pediatric Blood and Cancer
Volume	64
Issue number	10
DOIs	https://doi.org/10.1002/pbc.26491
Publication status	Published - Oct 2017

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.26491

Cite this

Moritake, H., Tanaka, S., Nakayama, H., Miyamura, T., Iwamoto, S., Shimada, A., Terui, K., Saito, A., Shiba, N., Hayashi, Y., Tomizawa, D., Taga, T., Goto, H., Hasegawa, D., Horibe, K., Mizutani, S., & Adachi, S. (2017). Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study. Pediatric Blood and Cancer, 64(10), Article e26491. https://doi.org/10.1002/pbc.26491

Moritake, H, Tanaka, S, Nakayama, H, Miyamura, T, Iwamoto, S, Shimada, A, Terui, K, Saito, A, Shiba, N, Hayashi, Y, Tomizawa, D, Taga, T, Goto, H, Hasegawa, D, Horibe, K, Mizutani, S & Adachi, S 2017, 'Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study', Pediatric Blood and Cancer, vol. 64, no. 10, e26491. https://doi.org/10.1002/pbc.26491

@article{6de4ed3306c147a280d0b11c9d8fcbcf,

title = "Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study",

author = "Hiroshi Moritake and Shiro Tanaka and Hideki Nakayama and Takako Miyamura and Shotaro Iwamoto and Akira Shimada and Kiminori Terui and Akiko Saito and Norio Shiba and Yasuhide Hayashi and Daisuke Tomizawa and Takashi Taga and Hiroaki Goto and Daisuke Hasegawa and Keizo Horibe and Shuki Mizutani and Souichi Adachi",

note = "Funding Information: We thank the physicians working at the institutions affiliated with the JPLSG who cooperated with this study by submitting the questionnaires, and the data center of JPLSG. This work was supported by a Grant-in-Aid for Clinical Research from Miyazaki University Hospital and a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology and by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED. The authors declare there is no conflict of interest.",

year = "2017",

month = oct,

doi = "10.1002/pbc.26491",

language = "English",

volume = "64",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - Outcome of relapsed core binding factor acute myeloid leukemia in children

T2 - A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

AU - Moritake, Hiroshi

AU - Tanaka, Shiro

AU - Nakayama, Hideki

AU - Miyamura, Takako

AU - Iwamoto, Shotaro

AU - Shimada, Akira

AU - Terui, Kiminori

AU - Saito, Akiko

AU - Shiba, Norio

AU - Hayashi, Yasuhide

AU - Tomizawa, Daisuke

AU - Taga, Takashi

AU - Goto, Hiroaki

AU - Hasegawa, Daisuke

AU - Horibe, Keizo

AU - Mizutani, Shuki

AU - Adachi, Souichi

N1 - Funding Information: We thank the physicians working at the institutions affiliated with the JPLSG who cooperated with this study by submitting the questionnaires, and the data center of JPLSG. This work was supported by a Grant-in-Aid for Clinical Research from Miyazaki University Hospital and a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology and by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED. The authors declare there is no conflict of interest.

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85013655972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013655972&partnerID=8YFLogxK

U2 - 10.1002/pbc.26491

DO - 10.1002/pbc.26491

M3 - Letter

C2 - 28233452

AN - SCOPUS:85013655972

SN - 1545-5009

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 10

M1 - e26491

ER -

Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this